Home › Cancer (all types) › NCT06814977
An Acupuncture Study for Cancer Survivors With Joint Pain
RecruitingHealthy volunteers welcome
Researching the Implementation of Acupuncture for Chronic Musculoskeletal Pain in Diverse Underserved Cancer Survivors (ReIMAGINE)
Who can join
Ages 18 and older · All sexes · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: * English- or Spanish-speaking adults * Non white or Hispanic women with a prior cancer diagnosis * Stable oncological disease or no evidence oncological of disease per clinical documentation or clinician assessment * Worst pain rated ≥4 on a 0-10 scale in the preceding week * ≥15 days with pain in the past 30 days * Pain lasting ≥1 month * Willing and able to complete questionnaires and other study activities * Willing and able to provide informed consent for the trial Exclusion Criteria: * Completed active treatment (chemotherapy, surgery, radiation, transplantation) \<4 weeks prior to study * Maintenance therapies are allowed * Pain attributed to inflammatory arthritis (e.g., rheumatoid arthritis, gout) * Other non-musculoskeletal pain syndromes (eg, headache, visceral abdominal pain, neuropathic pain) can be present as comorbid conditions if the patient reports musculoskeletal pain as the primary source of pain * Procedures involving affected joints within the last month or planned in the next 14 weeks * Acupuncture use for pain in the past three months * Implanted electronic device (e.g., pacemaker)
About the study
The purpose of this study is to see whether acupuncture is a practical (feasible) treatment for cancer survivors with joint pain.
What is being tested
- Acupuncture (procedure)
Sponsor: Memorial Sloan Kettering Cancer Center · Participants: 60 · Started: Jan 31, 2025
Contact the study team
- Kevin Liou, MD · Phone: 646-608-8563
Official record on ClinicalTrials.gov — NCT06814977
Locations in the U.S.
| New York | Memorial Sloan Kettering Cancer Center (All protocol activites), New York Jamaica Hospital Medical Center, Richmond Hill |
Conditions
From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.